Kalytera Therapeutics Inc.

(SMQ.H:CA)

By |

Profile

Kalytera Therapeutics Inc is engaged in the development of a next generation of cannabinoid therapeutics. The company is developing CBD formulations and prodrugs to target specific disease sites within the body.

Contact Information

Website: www.kalytera.co
Email: lisa-marie@delavaco.com
Main Phone: +1 415 218-3900
Address: 41 Thunderbird Drive
Address 2: Suite 212
State: CA
City / Town: Novato
Country: USA
Postal Code: 94949

Issuer Information

Exchange: CDX
CEO: Robert E. Farrell
NAICS: Pharmaceutical Preparation Manufacturing (325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 191,668,592.00 EPS (TTM) -0.32 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.3 0.3 0.3 0.3
Low Target Price Estimate 0.3 0.3 0.3 0.3
Mean Target Price Estimate 0.3 0.3 0.3 0.3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/08/11 08/08/11 08/08/11 08/08/11
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1